Crossmark

Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study

Published Online: 2017-01-13

Published Print: 2017-12

Authors

Gargiulo, Giuseppe

Stabile, Eugenio

Ferrone, Marco

Barbato, Emanuele

Zimmermann, Frederik M.

Adjedj, Julien

Hennigan, Barry

Matsumura, Mitsuaki

Johnson, Nils P.

Fearon, William F.

Jeremias, Allen

Trimarco, Bruno

Esposito, Giovanni

,
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02184117 at ClinicalTrials.gov

Documents that mention this clinical trial

Prognostic value of microvascular resistance and its association to fractional flow reserve: a DEFINE-FLOW substudy
https://doi.org/10.1136/openhrt-2022-001981

Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study
https://doi.org/10.1186/s12933-016-0494-2
License Information

Text and Data Mining valid from 2017-01-13

Version of Record valid from 2017-01-13
More Information

Article History

Received: 30 October 2016

Accepted: 30 December 2016

First Online: 13 January 2017

Document is current